N@N

Steve Anderson Named Vice President of Product Development for Immersion?s Medical Line of Business

^{Published on 2009-02-19 07:56:41, Last Modified on 2009-02-19 07:58:08 - Market Wire}
 

SAN JOSE, Calif.--([ BUSINESS WIRE ])--Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, today announced that Steve Anderson has been named vice president of product development for Immersion's Medical line of business.

"In our Medical line of business, the focus for 2009 is on execution and deepening customer relationships. Steve will be central to both strategic themes," said Dan Chavez, senior vice president and general manager of Immersion's Medical line of business. "He is a strong senior leader with extensive technology expertise who will lead our global development teams in growing market share, improving customer experiences, and providing technology for the next generation of medical simulation. He will lead our efforts to build a new platform using the latest advances in software, hardware, and graphic simulation, supplying the new, full-fidelity healthcare educational experience."

Before joining Immersion, Anderson served as vice president of Software Engineering at LeapFrog Enterprises. He was a technology leader at Electronic Arts serving in a variety of roles including vice president, Studio COO, Studio CTO, and director of Graphics Technology. Earlier in his career, he worked at Silicon Graphics, where he created technology and managed R&D teams for consumer graphics products. He holds a bachelor's and a master's degree in Computer and Information Sciences from The Ohio State University.

"Entertainment has always pushed the limits of 3D computer graphics and simulation technology. I see a unique and compelling opportunity to draw on my 24 years in gaming, computer graphics, and product development to help Immersion capture the unquestioned market demand in the medical simulation market," said Anderson.

About Immersion's Medical Line of Business

Immersion designs, manufactures, and markets computer-based surgical simulation training systems worldwide. The medical and surgical simulators integrate proprietary computer software and tactile feedback robotics to create highly realistic medical simulations that help train clinicians. The company's key product lines are the LaparoscopyVR surgical simulation system, Endoscopy AccuTouch(R) simulator, CathLabVR surgical simulator, and the Virtual IV system.

About Immersion([ www.immersion.com ])

Founded in 1993, Immersion Corporation is the recognized leader in developing, licensing, and marketing digital touch technology and products. Using Immersion's advanced touch feedback technology electronic user interfaces are more compelling, entertaining, and in many applications, safer and more productive. Immersion's technology has helped manufacturers develop innovative and creative solutions for products such as hundreds of video games and leading video console gaming systems, medical training simulators installed around the world, driver controls for automotive manufacturers, and mobile phones, such as those from LG and Samsung. Immersion's patent portfolio includes over 700 issued or pending patents in the U.S. and other countries.

Forward-Looking Statements

This press release contains "forward-looking statements" that involve risks and uncertainties as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Immersion Corporation and its consolidated subsidiaries to differ materially from those expressed or implied by such forward-looking statements.

All statements, other than the statements of historical fact, are statements that may be deemed forward-looking statements, including statement regarding Steve Anderson leading our global development teams in growing market share, improving customer experiences, and providing technology for the next generation of medical simulation, the statement regarding Steve Anderson leading our efforts to build a new platform using the latest advances in software, hardware, and graphic simulation, supplying the new, full-fidelity healthcare educational experience, and the statement regarding helping Immersion capture the unquestioned market demand in the medical simulation market; and statements of belief or assumptions underlying any of the foregoing. Immersion's actual results might differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with Immersion's business, which include but are not limited to delay in or failure to achieve commercial demand for Immersion's expanded technology offerings; a delay in or failure to achieve the acceptance of force feedback as a critical user experience in the medical education and training markets; risks and uncertainties associated with ongoing and prospective litigation; and the general economic downturn.

For a more detailed discussion of these factors and other factors that could cause Immersion's actual results to vary materially, interested parties should review the risk factors listed in Immersion's most current Form 10-Q, which is on file with the U.S. Securities and Exchange Commission. The forward-looking statements in this press release reflect Immersion's beliefs and predictions as of the date of this release. Immersion disclaims any obligation to update these forward-looking statements as a result of financial, business, or any other developments occurring after the date of this release.

Immersion, the Immersion logo, AccuTouch, CathLabVR, and LaparoscopyVR are trademarks of Immersion Corporation in the United States and other countries. All other trademarks are the property of their respective owners.

IMMR – ME